Cardiovascular Business (@cardiobusiness) 's Twitter Profile
Cardiovascular Business

@cardiobusiness

Strategies in Economics, Practice and Technology. Subscribe to our newsletter: ow.ly/Vv8T50NQHhW

ID: 67655176

linkhttp://www.cardiovascularbusiness.com calendar_today21-08-2009 16:52:53

19,19K Tweet

8,8K Followers

1,1K Following

Cardiovascular Business (@cardiobusiness) 's Twitter Profile Photo
Cardiovascular Business
@cardiobusiness

5 months ago

Next up at #ACC24 is a big one: #TAVR vs SAVR among low-risk patients. Moritz Seiffert presented data showing TAVR was noninferior to SAVR after 1 year - in fact, it was linked to many benefits. A variety of TAVR valves were used as opposed to focusing on one manufacturer/design.

Next up at #ACC24 is a big one: #TAVR vs SAVR among low-risk patients. <a href="/MoritzSeiffert/">Moritz Seiffert</a> presented data showing TAVR was noninferior to SAVR after 1 year - in fact, it was linked to many benefits. A variety of TAVR valves were used as opposed to focusing on one manufacturer/design.